Literature DB >> 7552102

Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies.

A Benigni1.   

Abstract

The sensitivity of the renal vasculature to endothelin-1 together with the effect of the peptide on the kidney prompted investigators to study the role of endothelin-1 in renal pathophysiology. The kidney expresses both endothelinA and endothelinB receptors, which differ from species to species. Experiments employing specific endothelin receptor antagonists in experimental animals have suggested a role for endothelin-1 in ischaemia-induced acute renal failure and renal disease progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552102     DOI: 10.1097/00041552-199507000-00011

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  6 in total

Review 1.  Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Authors:  Emaad M Abdel-Rahman; Lawand Saadulla; W Brian Reeves; Alaa S Awad
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

Review 2.  Endothelin-1 as a target for therapeutic intervention in prostate cancer.

Authors:  E Scott Kopetz; Joel B Nelson; Michael A Carducci
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

3.  Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis.

Authors:  Yuqing Chen; Manjula Mahata; Fangwen Rao; Srikrishna Khandrika; Maite Courel; Maple M Fung; Kuixing Zhang; Mats Stridsberg; Michael G Ziegler; Bruce A Hamilton; Michael S Lipkowitz; Laurent Taupenot; Caroline Nievergelt; Sushil K Mahata; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2009-06-11       Impact factor: 10.121

4.  Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice.

Authors:  Ben Fogelgren; Shiming Yang; Ian C Sharp; Odaro J Huckstep; Wenbin Ma; S J Somponpun; Edward C Carlson; Catherine F T Uyehara; Scott Lozanoff
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-04

5.  Homology modeling, active site prediction, and targeting the anti hypertension activity through molecular docking on endothelin - B receptor domain.

Authors:  Daddam Jayasimha Rayalu; Chandrabose Selvaraj; Sanjeev Kumar Singh; Ramakrishan Ganeshan; Nagapatla Udaya Kumar; Panthangi Seshapani
Journal:  Bioinformation       Date:  2012-01-20

Review 6.  Therapeutic Advances in Diabetic Nephropathy.

Authors:  Hanny Sawaf; George Thomas; Jonathan J Taliercio; Georges Nakhoul; Tushar J Vachharajani; Ali Mehdi
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.